Answers are grounded in this paper and cite their sources.
Formulation of oridonin-loaded liposomes improved delivery in lung cancer, highlighting a new therapeutic option.
In conclusion, the constructed ORI-loaded liposomes might be a novel and promising delivery system for ORI in the treatment of lung cancer.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: